Day one of the 2026 European Academy of Optometry and Optics Congress was action packed with the engaging opening ceremony, HOYA Supported Presentations and MiYOSMART Case Study Contest! On Day 2, don’t miss out on the HOYA Vision Care Symposium where Dr Natalia Vlasak presents for the first time ever in Europe the new 12-month clinical trial results of our latest innovation – MiYOSMART iQ.   Discover how these findings represent the highest myopia‑control efficacy reported to date with D.I.M.S. Technology‑based spectacle lenses.   Mark your calendars to attend. #HOYAVisionCareGlobal #MiYOSMARTiQ #MyopiaManagement #MyopiaControl #EyeCare #EAOO2026 Product Disclaimer: Approval and availability of MiYOSMART and MiYOSMART iQ spectacle lenses for myopia control vary by country; they are not approved or available for sale in all countries, including the U.S

To view or add a comment, sign in

Explore content categories